Radiation Therapy News and Research

RSS
Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.
New drug shows strong activity against brain metastases in HER2-positive breast cancer

New drug shows strong activity against brain metastases in HER2-positive breast cancer

Hypofractionation proven safer and more convenient for breast cancer treatment

Hypofractionation proven safer and more convenient for breast cancer treatment

Long radiotherapy course shows better organ preservation in rectal cancer

Long radiotherapy course shows better organ preservation in rectal cancer

Pre-surgery chemotherapy shows promise for preserving vital organs in nasal and sinus cancer

Pre-surgery chemotherapy shows promise for preserving vital organs in nasal and sinus cancer

Advancing precision medicine with functional information in cancer treatment

Advancing precision medicine with functional information in cancer treatment

AI enhances understanding of radiation-induced cardiac arrhythmia risk in lung cancer patients

AI enhances understanding of radiation-induced cardiac arrhythmia risk in lung cancer patients

Targeted therapy slows endometrial cancer growth in mice models

Targeted therapy slows endometrial cancer growth in mice models

AI tools accelerate understanding of cardiac arrhythmia risks in lung cancer treatment

AI tools accelerate understanding of cardiac arrhythmia risks in lung cancer treatment

New exosome-based drug delivery system enhances ovarian cancer treatment

New exosome-based drug delivery system enhances ovarian cancer treatment

Novel exosome-based drug delivery system for synergistic cancer treatment

Novel exosome-based drug delivery system for synergistic cancer treatment

Engineered NK cells with IL-21 show strong antitumor activity against glioblastoma

Engineered NK cells with IL-21 show strong antitumor activity against glioblastoma

USC Norris to open state-of-the-art cancer center in Newport Beach with advanced radiation therapy

USC Norris to open state-of-the-art cancer center in Newport Beach with advanced radiation therapy

From discovery to approval: Vorasidenib approved by FDA for treatment of IDH-mutant gliomas

From discovery to approval: Vorasidenib approved by FDA for treatment of IDH-mutant gliomas

Ensuring sustainable and responsible use of AI in healthcare

Ensuring sustainable and responsible use of AI in healthcare

Combining radiation with chemotherapy enhances survival in oligometastatic pancreatic cancer

Combining radiation with chemotherapy enhances survival in oligometastatic pancreatic cancer

Breakthrough research identifies pathway used by glioblastoma to infiltrate the brain

Breakthrough research identifies pathway used by glioblastoma to infiltrate the brain

Breakthrough X-ray-sensitizers could revolutionize radiotherapy for cancer patients

Breakthrough X-ray-sensitizers could revolutionize radiotherapy for cancer patients

Distinct patient preference profiles identified in prostate cancer care

Distinct patient preference profiles identified in prostate cancer care

Electrical currents could supercharge cancer-killing immune cells, study finds

Electrical currents could supercharge cancer-killing immune cells, study finds

FAU researcher wins $701,000 grant to revolutionize cancer treatment

FAU researcher wins $701,000 grant to revolutionize cancer treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.